{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:28:25Z","timestamp":1778646505849,"version":"3.51.4"},"reference-count":42,"publisher":"China Science Publishing & Media Ltd.","issue":"2","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.3724\/abbs.2021019","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T03:23:08Z","timestamp":1640920988000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":22,"title":["LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells"],"prefix":"10.3724","volume":"54","author":[{"given":"Jing","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangzhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longyun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2174\/1381612826666200115093835","volume":"26","author":"Gupta M","year":"2020","unstructured":"Gupta M, Chandan K, Sarwat M. Role of microRNA and long non-coding RNA in hepatocellular carcinoma. Curr Pharm Des, 2020, 26: 415-428.","journal-title":"Curr Pharm Des"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","volume":"18","author":"Wei L","year":"2019","unstructured":"Wei L, Wang X, Lv L, Liu J, Xing H, Song Y, Xie M. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer, 2019, 18:","journal-title":"Mol Cancer"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11523-017-0484-7","volume":"12","author":"Keating GM","year":"2017","unstructured":"Keating GM. Sorafenib: a review in hepatocellular carcinoma. Targ Oncol, 2017, 12: 243-253.","journal-title":"Targ Oncol"},{"key":"CITATION4","doi-asserted-by":"crossref","unstructured":"Mendez-Blanco C, Fondevila F, Garcia-Palomo A, et al. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Exp Mol Med 2018, 50: 1-9.","DOI":"10.1038\/s12276-018-0159-1"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.bbrc.2018.02.141","volume":"497","author":"Yang Y","year":"2018","unstructured":"Yang Y, Jiang C, Yang Y, Guo L, Huang J, Liu X, Wu C. Silencing of LncRNA-HOTAIR decreases drug resistance of non-small cell lung cancer cells by inactivating autophagy via suppressing the phosphorylation of ULK1. Biochem Biophys Res Commun, 2018, 497: 1003-1010.","journal-title":"Biochem Biophys Res Commun"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/OTT.S175176","volume":"12","author":"Ye J","year":"2019","unstructured":"Ye J, Zhang R, Du X, Chai W, Zhou Q. Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p. Onco Targets Ther, 2019, 12: 415-422.","journal-title":"Onco Targets Ther"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.18632\/aging.102455","volume":"11","author":"Gu N","year":"2019","unstructured":"Gu N, Wang X, Di Z, Xiong J, Ma Y, Yan Y\u2019, Qian Y. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p\/CPEB4 axis. Aging, 2019, 11: 10266-10283.","journal-title":"Aging"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.15252\/emmm.201606198","volume":"8","author":"Sas-Chen A","year":"2016","unstructured":"Sas-Chen A, Aure MR, Leibovich L, Carvalho S, Enuka Y, K\u00f6rner C, Polycarpou-Schwarz M. LIMT is a novel metastasis inhibiting lncRNA suppressed byEGF and downregulated in aggressive breast cancer. EMBO Mol Med, 2016, 8: 1052-1064.","journal-title":"EMBO Mol Med"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.2147\/OTT.S256148","volume":"13","author":"Li M","year":"2020","unstructured":"Li M, Guo X. LINC01089 blocks the proliferation and metastasis of colorectal cancer cells via regulating miR-27b-3p\/HOXA10 axis. Onco Targets Ther, 2020, 13: 8251-8260.","journal-title":"Onco Targets Ther"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jb\/mvy047","volume":"164","author":"Saitoh M","year":"2018","unstructured":"Saitoh M. Involvement of partial EMT in cancer progression. J Biochem, 2018, 164: 257-264.","journal-title":"J Biochem"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/molecules21070965","volume":"21","author":"Du B","year":"2016","unstructured":"Du B, Shim JS. Targeting epithelial\u2013mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules, 2016, 21:","journal-title":"Molecules"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"188310","DOI":"10.1016\/j.bbcan.2019.188310","volume":"1872","author":"Aleksakhina SN","year":"2019","unstructured":"Aleksakhina SN, Kashyap A, Imyanitov EN. Mechanisms of acquired tumor drug resistance. BioChim Biophys Acta (BBA) - Rev Cancer, 2019, 1872:","journal-title":"BioChim Biophys Acta (BBA) - Rev Cancer"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"Mittal V","year":"2018","unstructured":"Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol Mech Dis, 2018, 13: 395-412.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7561879","volume":"2019","author":"Zhang X","year":"2019","unstructured":"Zhang X, Chen J, Jiang S, He S, Bai Y, Zhu L, Ma R. N-Acetyltransferase 10 enhances doxorubicin resistance in human hepatocellular carcinoma cell lines by promoting the epithelial-to-mesenchymal transition. Oxid Med Cell Longev, 2019, 2019: 1-14.","journal-title":"Oxid Med Cell Longev"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3892\/ijo.2018.4327","volume":"52","author":"Zhang Y","year":"2018","unstructured":"Zhang Y, Lu Y, Zhang C, Huang D, Wu W, Zhang Y, Shen J. FSCN\u20111 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition. Int J Oncol, 2018, 52:","journal-title":"Int J Oncol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.7150\/ijbs.32460","volume":"16","author":"Bao Y","year":"2020","unstructured":"Bao Y, Zhang Y, Lu Y, Guo H, Dong Z, Chen Q, Zhang X. Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition. Int J Biol Sci, 2020, 16: 827-837.","journal-title":"Int J Biol Sci"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"8420","DOI":"10.1111\/jcmm.14724","volume":"23","author":"Wu N","year":"2019","unstructured":"Wu N, Zhang X, Bao Y, Yu H, Jia D, Ma C. Down\u2010regulation of GAS5 ameliorates myocardial ischaemia\/reperfusion injury via the miR\u2010335\/ROCK1\/AKT\/GSK\u20103\u03b2 axis. J Cell Mol Med, 2019, 23: 8420-8431.","journal-title":"J Cell Mol Med"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"116440","DOI":"10.1016\/j.lfs.2019.04.066","volume":"233","author":"Li M","year":"2019","unstructured":"Li M, Duan L, Li Y, Liu B. Long noncoding RNA\/circular noncoding RNA\u2013miRNA\u2013mRNA axes in cardiovascular diseases. Life Sci, 2019, 233:","journal-title":"Life Sci"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2017.09.041","volume":"411","author":"Ma J","year":"2017","unstructured":"Ma J, Zeng S, Zhang Y, Deng G, Qu Y, Guo C, Yin L. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1\/ERK\/ELK1 signaling in hepatocellular carcinoma. Cancer Lett, 2017, 411: 117-129.","journal-title":"Cancer Lett"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.13642","volume":"109","author":"Sanchez Calle A","year":"2018","unstructured":"Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci, 2018, 109: 2093-2100.","journal-title":"Cancer Sci"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fonc.2019.01156","volume":"9","author":"Lai Y","year":"2019","unstructured":"Lai Y, Feng B, Abudoureyimu M, Zhi Y, Zhou H, Wang T, Chu X. Non-coding RNAs: emerging regulators of sorafenib resistance in hepatocellular carcinoma. Front Oncol, 2019, 9:","journal-title":"Front Oncol"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.2147\/OTT.S208830","volume":"12","author":"Yuan H","year":"2019","unstructured":"Yuan H, Qin Y, Zeng B, Feng Y, Li Y, Xiang T, Ren G. Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt\/\u03b2-catenin signaling pathway in breast cancer. Onco Targets Ther, 2019, 12: 4883-4895.","journal-title":"Onco Targets Ther"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12935-021-01846-7","volume":"21","author":"Zhang H","year":"2021","unstructured":"Zhang H, Zhang H, Li X, Huang S, Guo Q, Geng D. LINC01089 functions as a ceRNA for miR-152-3p to inhibit non\u2010small lung cancer progression through regulating PTEN. Cancer Cell Int, 2021, 21:","journal-title":"Cancer Cell Int"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12935-020-01561-9","volume":"20","author":"Guo X","year":"2020","unstructured":"Guo X, Li M. LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p\/TET1 axis. Cancer Cell Int, 2020, 20:","journal-title":"Cancer Cell Int"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"e3280","DOI":"10.1002\/jgm.3280","volume":"23","author":"Li S","year":"2021","unstructured":"Li S, Han Y, Liang X, Zhao M. LINC01089 inhibits the progression of cervical cancer via inhibiting miR\u201027a\u20103p and increasing BTG2. J Gene Med, 2021, 23:","journal-title":"J Gene Med"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9515071","volume":"2020","author":"Tang X","year":"2020","unstructured":"Tang X, Zhang W, Ye Y, Li H, Cheng L, Zhang M, Zheng S. LncRNA HOTAIR contributes to sorafenib resistance through suppressing miR-217 in hepatic carcinoma. Biomed Res Int, 2020, 2020: 1-10.","journal-title":"Biomed Res Int"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.3390\/ijms20225758","volume":"20","author":"Wang L","year":"2019","unstructured":"Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long Noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci, 2019, 20:","journal-title":"Int J Mol Sci"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.3802\/jgo.2018.29.e95","volume":"29","author":"Luan X","year":"2018","unstructured":"Luan X, Wang Y. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol, 2018, 29:","journal-title":"J Gynecol Oncol"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3892\/or.2018.6908","volume":"41","author":"Tang X","year":"2019","unstructured":"Tang X, Yang W, Shu Z, Shen X, Zhang W, Cen C, Cao L. MicroRNA\u2011223 promotes hepatocellular carcinoma cell resistance to sorafenib by targeting FBW7. Oncol Rep, 2019, 41:","journal-title":"Oncol Rep"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1158\/1078-0432.CCR-16-1464","volume":"23","author":"Fornari F","year":"2017","unstructured":"Fornari F, Pollutri D, Patrizi C, La Bella T, Marinelli S, Casadei Gardini A, Marisi G. In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3\u2013mediated apoptosis. Clin Cancer Res, 2017, 23: 3953-3965.","journal-title":"Clin Cancer Res"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41419-018-0978-y","volume":"9","author":"Hu Y","year":"2018","unstructured":"Hu Y, Yang C, Yang S, Cheng F, Rao J, Wang X. miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB. Cell Death Dis, 2018, 9:","journal-title":"Cell Death Dis"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"80666","DOI":"10.18632\/oncotarget.20881","volume":"8","author":"Qu Z","year":"2017","unstructured":"Qu Z, Wu J, Wu J, Ji A, Qiang G, Jiang Y, Jiang C. Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis. Oncotarget, 2017, 8: 80666-80678.","journal-title":"Oncotarget"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.3892\/ol.2020.11457","volume":"19","author":"Xia J","year":"2020","unstructured":"Xia J, Li D, Zhu X, Xia W, Qi Z, Li G, Xu Q. Upregulated miR\u2011665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion. Oncol Lett, 2020, 19:","journal-title":"Oncol Lett"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"100715","DOI":"10.1016\/j.drup.2020.100715","volume":"53","author":"Erin N","year":"2020","unstructured":"Erin N, Grahovac J, Brozovic A, Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resistance Updates, 2020, 53:","journal-title":"Drug Resistance Updates"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"Bakir B","year":"2020","unstructured":"Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol, 2020, 30: 764-776.","journal-title":"Trends Cell Biol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/abbs\/gmaa014","volume":"52","author":"Zhang X","year":"2020","unstructured":"Zhang X, Zhang J, Zhou H, Liu G, Li Q. Rho kinase mediates transforming growth factor-\u03b21-induced vasculogenic mimicry formation: involvement of the epithelial\u2013mesenchymal transition and cancer stemness activity. Acta Biochim Biophys Sin, 2020, 52: 411-420.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/tox.22938","volume":"35","author":"Yan L","year":"2020","unstructured":"Yan L, Yang S, Yue CX, Wei XY, Peng W, Dong ZY, Xu HN. Long noncodingRNA H19 acts as amiR \u2010340\u20103p sponge to promote epithelial\u2010mesenchymal transition by regulatingYWHAZ expression in paclitaxel\u2010resistant breast cancer cells. Environ Toxicol, 2020, 35: 1015-1028.","journal-title":"Environ Toxicol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/abbs\/gmy119","volume":"51","author":"Wang Y","year":"2019","unstructured":"Wang Y, Tai Q, Zhang J, Kang J, Gao F, Zhong F, Cai L. MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression. Acta Biochim Biophys Sin, 2019, 51: 243-253.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/abbs\/gmaa029","volume":"52","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Shi K, Liu H, Chen W, Luo Y, Wei X, Wu Z. miR-4458 inhibits the epithelial\u2013mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-\u03b2 signaling pathway via targeting TGFBR1. Acta Biochim Biophys Sin, 2020, 52: 554-562.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-016-0487-8","volume":"36","author":"Xu J","year":"2017","unstructured":"Xu J, Liu D, Niu H, Zhu G, Xu Y, Ye D, Li J. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res, 2017, 36:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9241769","volume":"2019","author":"Sun XH","year":"2019","unstructured":"Sun XH, Chang X, Wang Y, Xu B, Cao X. Oroxylin A suppresses the cell proliferation, migration, and EMT via NF- \u03ba B signaling pathway in human breast cancer cells. Biomed Res Int, 2019, 2019: 1-10.","journal-title":"Biomed Res Int"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943-017-0700-1","volume":"16","author":"Yang S","year":"2017","unstructured":"Yang S, Liu Y, Li MY, Ng CSH, Yang SL, Wang S, Zou C. FOXP3 promotes tumor growth and metastasis by activating Wnt\/\u03b2-catenin signaling pathway and EMT in non-small cell lung cancer. Mol Cancer, 2017, 16:","journal-title":"Mol Cancer"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/2752DD237F3749AE8C48CD3EFD470E6E","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2021019","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/2752DD237F3749AE8C48CD3EFD470E6E","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T16:25:52Z","timestamp":1652977552000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2021019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,23]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2021019","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,23]]}}}